Home Health Care News September 19, 2024
UnitedHealth Group’s (NYSE:UNH) acquisition of Amedisys (Nasdaq:AMED) is still pending. That could be due to a variety of factors, but one is clear: the Oregon Health Authority’s (OHA) ongoing review, which is expected to continue until at least the end of November.
OHA’s Health Care Market Oversight (HCMO) program reviews health care business deals to ensure they do not harm the state’s citizens or communities. In July, both UnitedHealth Group and Amedisys submitted responses to the OHA’s request for information. The authority is still seeking public comments on this matter.
In addition to the issue in Oregon, the deal has faced scrutiny from federal antitrust regulators, including the U.S. Department of Justice (DOJ).
Amedisys and UnitedHealth agreed to sell certain...
Today's Sponsors
Today's Sponsor